| COVID-19 | Coronavirus Disease 2019 |
| SARS | Severe Acute Respiratory Syndrome |
| SARS-CoV | Severe Acute Respiratory Syndrome Coronavirus |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| MERS | Middle East Respiratory Syndrome |
| BAL | Bronchoalveolar Lavage |
| EUA | Emergency Use Authorization |
| RT-PCR | Reverse Transcriptase Polymerase Chain Reaction |
| S | SARS-CoV-2 Spike Protein |
| E | SARS-CoV-2 Envelope Protein |
| M | SARS-CoV-2 Membrane Protein |
| NP | SARS-CoV-2 Nucleocapsid Protein |
| RBD | Receptor-Binding Domain |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| RDT | Rapid Diagnostic Test |
| CLIA | Chemiluminescence Immunoassay |
| LFIA | Lateral Flow Immunoassay |
| PoC | Point of Care |
| DABA | Double-Antigen-Bridging Assay |